BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Avicena Group, Inc. 



San Francisco  California    U.S.A.
Phone: N/A Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology

Segment
Drug Discovery





 Company News
Avicena Group, Inc.'s HD-02 to Proceed to National Institutes of Health (NIH) Sponsored Phase III Huntington's Disease Trial 3/12/2008 9:19:33 AM
Avicena Group, Inc. Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis 12/3/2007 8:15:41 AM
Data on Avicena Group, Inc.'s Drug Candidate HD-02 Presented at the 2007 World Congress on Huntington's Disease 11/19/2007 7:54:26 AM
USPTO Issues Patent for Avicena Group, Inc.'s Proprietary Compounds to Treat Amyotrophic Lateral Sclerosis Patent Expands Existing IP to Treat ALS 11/13/2007 7:49:49 AM
Survival Data for Avicena Group, Inc.'s Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND 10/18/2007 10:48:23 AM
Avicena Group, Inc. Appoints Dr. Belinda Tsao-Nivaggioli as Chairman of the Board of Directors 10/11/2007 10:08:54 AM
Avicena Group, Inc. to Present at 4th Annual Biotechnology Industry Organization (BIO) InvestorForum Conference Expansion of Drug Pipeline and Advancement of Clinical Programs 10/9/2007 11:39:31 AM
Avicena Group, Inc. Appoints Dr. M. Flint Beal to Board of Directors 9/28/2007 12:53:46 PM
Avicena Group, Inc. Announces Closing of Private Offering 9/26/2007 11:44:17 AM
Avicena Group, Inc. Reports Second Quarter 2007 Results 9/4/2007 8:09:10 AM
123456